August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

He is the principal Investigator for the NIH Fogarty International Center, HIV Research Training Program with the University of Zimbabwe, co-chair of the SUNY-University of the West Indies Faculty ...

These programs integrate with the NIH Fogarty International Center AIDS International Training and Research Program, which Morse directs with the University of Zimbabwe and is home to the Center of ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...

By David Stephen The sweeping and aggressive cuts to research funding at the National Institutes of Health [NIH] suggests that it may be likely that several of the Institutes and […] ...

Held in March 2025 under the EMPOWER-TZ program, funded by the Fogarty International Center at National Institutes of Health (NIH), the symposium was organized by the Johns Hopkins Schools of Medicine ...

Funding The study was supported by the Johns Hopkins Center for Global Health (Principal Investigator NNH) and the Fogarty International Center, National Institutes of Health (NIH; grant R24 TW007988) ...

In the United States, the Food and Drug Administration (FDA) does not regulate dietary supplements the way it regulates prescription medications. As a result, some supplement products may not contain ...

“Nobody feels like their job is safe. Everyone is on edge,” said Kim Hasenkrug, an NIH scientist emeritus with knowledge of ongoing activities at Rocky Mountain Laboratories. “They’re ...